levofloxacin has been researched along with HIV Infections in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (17.65) | 18.2507 |
| 2000's | 3 (17.65) | 29.6817 |
| 2010's | 8 (47.06) | 24.3611 |
| 2020's | 3 (17.65) | 2.80 |
| Authors | Studies |
|---|---|
| Cohen, DE; Kanaya, F; Mayer, KH; Szumowski, JD | 1 |
| Akram, B; Drevets, DA; Gujju, VR; McGhee, MA; Shibib, DR | 1 |
| Dodd, PJ; Mafirakureva, N; McQuaid, CF; Seddon, JA | 1 |
| Buset, M; De Wit, S; Delforge, M; Gomez-Galdon, M; Miendje-Deyi, VY; Muls, V; Nkuize, M; Vanderpas, J | 1 |
| Denti, P; Dooley, KE; Draper, HR; Garcia-Prats, AJ; Hesseling, AC; McIlleron, HM; Savic, RM; Schaaf, HS; Thee, S; Wiesner, L; Winckler, J | 1 |
| Hendrich, AB; Kicia, M; Kopacz, Ż; Kváč, M; Sak, B; Sędzimirska, M; Wesołowska, M | 1 |
| Boulle, A; Fox, T; Khomo, N; Kock, Y; Leslie, J; Manning, K; Meintjes, G; Mudaly, V; Stewart, A; Tiffin, N; Wasserman, S; Zhao, Y | 1 |
| Bantubani, N; Chotoo, S; Conradie, F; Enwerem, M; Ferreira, H; Hughes, J; Ismail, N; Maartens, G; Master, I; Meintjes, G; Mohr, E; Ndjeka, N; Padanilam, X; Romero, R; Schnippel, K; Singh, N; Te Riele, J; Variava, E | 1 |
| Cabrera, A; Domenech, N; Hernández Bel, L; Moratal E Cervera, B | 1 |
| Bang, ND; Caws, M; Chau, NV; Chau, TT; Day, JN; Dung, NH; Farrar, JJ; Ha, DT; Heemskerk, AD; Hien, NQ; Hien, TT; Lan, NH; Lan, NN; Lan, NT; Loc, PP; Mai, NT; Merson, L; Phong, le T; Phu, NH; Thinh, TT; Thwaites, GE; Vien, NN; Wolbers, M; Yen, NT | 1 |
| Adebola, SO; Adedeji, TO; Adefuye, BO; Oladeji, SM; Sogebi, OA | 1 |
| Bang, ND; Caws, M; Chau, TT; Day, J; Dung, NH; Farrar, J; Heemskerk, D; Merson, L; Olliaro, P; Pouplin, T; Wolbers, M; Yen, NT | 1 |
| Carosi, G; Casari, S; Chiodera, A; Moretti, F; Quiros-Roldan, E; Viale, P | 1 |
| Bartlett, JA; Chow, AT; Flor, SC; Gallis, HA; Goodwin, SD; Wong, FA | 1 |
| Chien, SC; Chow, AT; Hendrix, CW; Rogge, MC; Williams, RR | 1 |
| Baird, B; Chow, AT; Fowler, CL; Masur, H; Natarajan, J; Piscitelli, SC; Spooner, K; Walker, RE; Williams, RR | 1 |
| Cadeo, B; Carosi, G; Fiocchi, C; Marchetti, F; Regazzi, MB; Signorini, L; Viale, P; Villani, A; Villani, P | 1 |
1 review(s) available for levofloxacin and HIV Infections
| Article | Year |
|---|---|
Bordetella bronchiseptica infections in patients with HIV/AIDS: A case report and review of the literature.
Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Bordetella bronchiseptica; Bordetella Infections; HIV Infections; Humans; Levofloxacin; Male; Middle Aged | 2021 |
6 trial(s) available for levofloxacin and HIV Infections
| Article | Year |
|---|---|
Intensified Antituberculosis Therapy in Adults with Tuberculous Meningitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Double-Blind Method; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; HIV Infections; Humans; Kaplan-Meier Estimate; Levofloxacin; Male; Middle Aged; Mycobacterium tuberculosis; Proportional Hazards Models; Rifampin; Tuberculosis, Meningeal | 2016 |
Intensified treatment with high dose rifampicin and levofloxacin compared to standard treatment for adult patients with tuberculous meningitis (TBM-IT): protocol for a randomized controlled trial.
Topics: Adult; Antitubercular Agents; Disability Evaluation; Double-Blind Method; Drug Therapy, Combination; HIV Infections; Humans; Levofloxacin; Neurologic Examination; Ofloxacin; Research Design; Rifampin; Sample Size; Time Factors; Treatment Outcome; Tuberculosis, Meningeal; Vietnam | 2011 |
Pharmacokinetics and safety of levofloxacin in patients with human immunodeficiency virus infection.
Topics: Absorption; Adolescent; Adult; Chromatography, High Pressure Liquid; Double-Blind Method; Half-Life; HIV Infections; Humans; Levofloxacin; Male; Ofloxacin; Tissue Distribution | 1994 |
Pharmacokinetics and safety of oral levofloxacin in human immunodeficiency virus-infected individuals receiving concomitant zidovudine.
Topics: Adult; Anti-HIV Agents; Anti-Infective Agents; Double-Blind Method; Drug Interactions; HIV Infections; Humans; Levofloxacin; Male; Ofloxacin; Zidovudine | 1997 |
Pharmacokinetics and safety of high-dose and extended-interval regimens of levofloxacin in human immunodeficiency virus-infected patients.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Area Under Curve; CD4 Lymphocyte Count; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Half-Life; HIV Infections; Humans; Intestinal Absorption; Levofloxacin; Male; Ofloxacin | 1999 |
Pharmacokinetic evaluation of oral levofloxacin in human immunodeficiency virus-infected subjects receiving concomitant antiretroviral therapy.
Topics: Administration, Oral; Alkynes; Anti-HIV Agents; Anti-Infective Agents; Benzoxazines; Cohort Studies; Cyclopropanes; Drug Interactions; HIV Infections; Humans; Levofloxacin; Nelfinavir; Ofloxacin; Oxazines; Prospective Studies | 2001 |
10 other study(ies) available for levofloxacin and HIV Infections
| Article | Year |
|---|---|
Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic.
Topics: Adult; Ambulatory Care Facilities; Anti-Bacterial Agents; Boston; Female; HIV Infections; Humans; Male; Methicillin Resistance; Middle Aged; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Treatment Outcome | 2007 |
The global impact of household contact management for children on multidrug-resistant and rifampicin-resistant tuberculosis cases, deaths, and health-system costs in 2019: a modelling study.
Topics: Adult; Antitubercular Agents; Child; HIV Infections; Humans; Levofloxacin; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2022 |
Primary antibiotic resistance of Helicobacter pylori isolates is twofold more frequent in HIV-positive than HIV-negative individuals: A descriptive observational study.
Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; HIV Infections; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Young Adult | 2021 |
Levofloxacin Population Pharmacokinetics in South African Children Treated for Multidrug-Resistant Tuberculosis.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antitubercular Agents; Area Under Curve; Child; Child, Preschool; Coinfection; Drug Administration Schedule; Drug Dosage Calculations; Female; HIV; HIV Infections; Humans; Infant; Levofloxacin; Male; Models, Statistical; Mycobacterium tuberculosis; Prospective Studies; South Africa; Tablets; Tuberculosis, Multidrug-Resistant | 2018 |
Respiratory microsporidiosis caused by Enterocytozoon bieneusi in an HIV-negative hematopoietic stem cell transplant recipient.
Topics: Albendazole; Bronchoalveolar Lavage; Enterocytozoon; Female; Hematopoietic Stem Cell Transplantation; HIV Infections; Humans; Immunocompromised Host; Levofloxacin; Microsporidiosis; Risk Factors; Urinary Tract Infections; Young Adult | 2018 |
Improved Treatment Outcomes With Bedaquiline When Substituted for Second-line Injectable Agents in Multidrug-resistant Tuberculosis: A Retrospective Cohort Study.
Topics: Adult; Antitubercular Agents; Coinfection; Diarylquinolines; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethionamide; Female; HIV; HIV Infections; Humans; Isoniazid; Isoxazoles; Levofloxacin; Male; Mycobacterium tuberculosis; Oxazolidinones; Pyrazinamide; Retrospective Studies; South Africa; Survival Analysis; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2019 |
High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen.
Topics: Adult; Anti-HIV Agents; Antitubercular Agents; Clofazimine; Diarylquinolines; Drug Resistance, Bacterial; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Female; Fluoroquinolones; HIV Infections; Humans; Levofloxacin; Linezolid; Male; Middle Aged; Poisson Distribution; South Africa; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2018 |
[Retinal folds as a non-reported secondary effect of darunavir in a 20 year-old HIV patient].
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Darunavir; Female; HIV Infections; HIV Protease Inhibitors; Humans; Levofloxacin; Meropenem; Ophthalmoscopy; Pneumonia, Pneumococcal; Polypharmacy; Retinal Dystrophies; Thienamycins; Young Adult | 2015 |
Clinical predictors of aminoglycoside-induced ototoxicity in drug-resistant Tuberculosis patients on intensive therapy.
Topics: Adult; Age Factors; Aminoglycosides; Antitubercular Agents; Audiometry, Pure-Tone; Body Mass Index; Coinfection; Comorbidity; Cycloserine; Diabetes Mellitus; Female; Hearing Loss; HIV Infections; Humans; Kanamycin; Levofloxacin; Male; Middle Aged; Nigeria; Prospective Studies; Prothionamide; Pyrazinamide; Risk Factors; Time Factors; Tuberculosis, Multidrug-Resistant; Young Adult | 2017 |
Rhodococcus equi: pulmonary cavitation lesion in patient infected with HIV cured by levofloxacin and rifampicin.
Topics: Actinomycetales Infections; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Drug Therapy, Combination; HIV Infections; Humans; Levofloxacin; Lung Diseases; Male; Ofloxacin; Rhodococcus equi; Rifampin | 2002 |